Description of Collaborative Activity: |
The Influenza Risk Management Meetings provide members (including ASPR/BARDA, CDC, FDA, and NIH) with a venue to discuss issues relating to the U.S. Department of Health and Human Services (HHS) response to pandemic influenza. Subjects for discussion include but are not limited to considerations of vaccine and antiviral stockpiles and clinical trial response to influenza outbreaks such as H7N9 and H3N2v. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
